Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 92 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 7476382

    Reovirus for the treatment of neoplasia

    ONCOLYTICS BIOTECH INC. · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  2. US 7476657

    Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  3. US 7470660

    Treatment for dark adaptation

    The Regents of the University of California · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  4. US 7470431

    Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

    The Regents of the University of Colorado · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  5. US 7468419

    Cyclosporin derivatives for the treatment of immune disorders

    Enanta Pharmaceuticals, Inc. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  6. US 7465715

    Method for treatment of multiple sclerosis

    CAN-FITE BIOPHARMA LTD. · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  7. US 7455845

    Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure

    The Regents of the University of Colorado · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  8. US 7452723

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  9. US 7449570

    Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

    PTC THERAPEUTICS, INC. · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted

  10. US 7449192

    Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction

    The Regents of the University of Colorado · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted

  11. US 7438931

    Methods and compositions for the treatment of angiogenic diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted

  12. US 7429387

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted

  13. US 7423015

    Antihelminthic drugs as a treatment for hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted

  14. US 7422738

    Combined cancer treatment methods using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted

  15. US 7420030

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  16. US 7417037

    Compositions and methods of treatment for inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted

  17. US 7416741

    Copper lowering treatment of inflammatory and fibrotic diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted

  18. US 7416724

    Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted

  19. US 7413870

    SAK: modulation of cellular proliferation for treatment of cancer

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted

  20. US 7413873

    Method of detection and treatment of colon cancer

    The Regents of the University of California · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted

  21. US 7410981

    Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted

  22. US 7405233

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  23. US 7405314

    Compounds and methods for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  24. US 7402567

    Treatment of disease by inducing cell apoptosis

    The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.